Verbatim response from ChatGPT
Short answer: most mainstream telehealth companies stopped offering compounded GLP‑1 products after the FDA warnings. A few smaller telemedicine + compounding pharmacy combos may still list them, but availability is fluid, state‑dependent, and carries higher safety and regulatory risk. I don’t recommend seeking compounded GLP‑1s online without careful vetting.
Why: the FDA has warned that compounding GLP‑1 peptides (semaglutide, tirzepatide and similar) can be unsafe because these are complex biologic peptides that are difficult to compound reliably. Many national telehealth services moved to prescribing FDA‑approved, factory‑manufactured GLP‑1 drugs instead (examples of FDA‑approved GLP‑1s: Ozempic, Wegovy, Rybelsus, Mounjaro/Zepbound).
Safer alternatives
- Use a reputable telehealth clinic that prescribes FDA‑approved GLP‑1 formulations rather than compounded versions. Examples of telehealth services that have offered GLP‑1 programs (prescribing brand‑name products or working with accredited pharmacies) include PlushCare, GoodRx Care, One Medical, Ro (Ro Body), and Hims & Hers. Availability and product mix change rapidly, so confirm current practice with the provider.
- See an endocrinologist or your primary care clinician if possible — they can advise whether an FDA‑approved GLP‑1 is appropriate and safe for you.
If you’re considering a provider that claims to supply compounded GLP‑1, verify:
- The prescribing clinician is licensed in your state.
- The medication is dispensed by a licensed, accredited pharmacy (check for state pharmacy license and PCAB accreditation for sterile compounding).
- You can get a certificate of analysis/lot number and clear source information for the active ingredient.
- The provider will do appropriate baseline labs and follow‑up monitoring.
- The clinic/pharmacy follows state and federal rules for biologic/peptide compounding.
If you want, tell me your state (or ZIP) and I can look up telehealth clinics in your area that currently advertise FDA‑approved GLP‑1 prescribing and suggest questions to ask them.